Your browser doesn't support javascript.
loading
Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.
Chung, Hyun Cheol; Kok, Victor C; Cheng, Rebecca; Hsu, Yanzhi; Orlando, Mauro; Fuchs, Charles; Cho, Jae Yong.
Afiliação
  • Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Kok VC; Division of Medical Oncology, Department of Internal Medicine, Kuang Tien General Hospital, Taichung, Taiwan.
  • Cheng R; Eli Lilly and Company, Taipei, Taiwan.
  • Hsu Y; Eli Lilly and Company, Indianapolis, IN, USA.
  • Orlando M; Eli Lilly and Company, Buenos Aires, Argentina.
  • Fuchs C; Yale Cancer Center, New Haven, CT, USA.
  • Cho JY; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Asia Pac J Clin Oncol ; 14(3): 204-209, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29318751

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Asia Pac J Clin Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article